These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36564986)

  • 1. Dermatophytoses Severity Score - A novel point-of-care scoring tool to assess the severity of dermatophytosis.
    Bhat RM; Madhumita M; Jayaraman J
    Mycoses; 2023 Apr; 66(4):354-361. PubMed ID: 36564986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-mycological validation of dermatophytosis severity score and its correlation with patient-reported outcome measures.
    Bhat RM; Madhumita M; Jayaraman J; Antony B; Santosh G; Benny JV; Ancy A
    Mycoses; 2024 Aug; 67(8):e13783. PubMed ID: 39135217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lichen Planus Severity Index: A new, valid scoring system to assess the severity of cutaneous lichen planus.
    Kaur H; Nikam BP; Jamale VP; Kale MS
    Indian J Dermatol Venereol Leprol; 2020; 86(2):169-175. PubMed ID: 31898636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical characteristics of itch in epidemic-like scenario of dermatophytoses in India: a cross-sectional study.
    Verma S; Vasani R; Reszke R; Matusiak Ł; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):180-183. PubMed ID: 31419346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index.
    Carney C; Tosti A; Daniel R; Scher R; Rich P; DeCoster J; Elewski B
    Arch Dermatol; 2011 Nov; 147(11):1277-82. PubMed ID: 22106113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of dermatophytoses in Brazil: a systematic review.
    de Oliveira Pereira F; Gomes SM; Lima da Silva S; Paula de Castro Teixeira A; Lima IO
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33533707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of dermatophytosis in northeast of Iran (Mashhad) and review of published studies.
    Naseri A; Fata A; Najafzadeh MJ; Shokri H
    Mycopathologia; 2013 Oct; 176(3-4):247-53. PubMed ID: 23943426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India.
    Pathania S; Rudramurthy SM; Narang T; Saikia UN; Dogra S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):678-684. PubMed ID: 30058568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on quality of life in patients with dermatophytosis.
    Mushtaq S; Faizi N; Amin SS; Adil M; Mohtashim M
    Australas J Dermatol; 2020 May; 61(2):e184-e188. PubMed ID: 31691274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Little Discussed Anatomical Locations in Superficial Dermatophytosis Sundry Observations and Musings.
    Verma S; Vasani R; Gupta S
    Indian Dermatol Online J; 2020; 11(3):419-424. PubMed ID: 32695707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
    Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
    BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Shenoy MM; Rengasamy M; Dogra S; Kaur T; Asokan N; Sarveswari KN; Poojary S; Arora D; Patil S; Das A; Srivastava A; Katakam BK; Mahajan V
    Mycoses; 2022 Jan; 65(1):13-23. PubMed ID: 34378240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and psychological morbidity in patients with superficial cutaneous dermatophytosis.
    Narang T; Bhattacharjee R; Singh S; Jha K; Kavita ; Mahajan R; Dogra S
    Mycoses; 2019 Aug; 62(8):680-685. PubMed ID: 31102543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in the treatment and diagnosis of dermatophytosis?
    Laniosz V; Wetter DA
    Semin Cutan Med Surg; 2014 Sep; 33(3):136-9. PubMed ID: 25577854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatophytes and dermatophytosis in the eastern and southern parts of Africa.
    Nweze EI; Eke IE
    Med Mycol; 2018 Jan; 56(1):13-28. PubMed ID: 28419352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.
    Singh S; Shukla P
    Indian J Dermatol Venereol Leprol; 2018; 84(5):554-557. PubMed ID: 29893296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory dermatophytoses of glabrous skin and their treatment].
    Grigoriu D; Baudraz-Rosselet F
    Ther Umsch; 1984 Jun; 41(6):397-402. PubMed ID: 6463909
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of superficial dermatophytoses epidemic in India on patients' quality of life.
    Verma S; Vasani R; Reszke R; Matusiak L; Szepietowski JC
    Postepy Dermatol Alergol; 2021 Feb; 38(2):102-105. PubMed ID: 34408575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.